Sage Journals: Discover world-class research

Open access

Research article

First published 2023-10

Complement Component 5 (C5) Deficiency Improves Cognitive Outcome After Traumatic Brain Injury and Enhances Treatment Effects of Complement Inhibitors C1-Inh and CR2-Crry in a Mouse Model

Min Chen, Stephen R. Edwards, Dhiraj Maskey [...]

Neurotrauma Reports

Open access

Review article

First published 2019

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria

Robert M. Stern, Nathan T. Connell

Therapeutic Advances in Hematology

Open access

Research article

First published 2025

Managing transient immune complex reactions in patients with paroxysmal nocturnal hemoglobinuria: clinical observations from the COMMODORE 1 and 2 studies

Austin G. Kulasekararaj, Jun-Ichi Nishimura, Alexander Röth [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2014-10

Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies

Z Romay-Penabad, AL Carrera Marin, R Willis [...]

Lupus

Open access

Case report

First published 2023

Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report

Valentina Bruno, David Barth, Arenn Jauhal

Canadian Journal of Kidney Health and Disease

Retricted access

Research article

First published 2001-12

Synthesis of Oligonucleotide Inhibitors of DNA (Cytosine-C5) Methyltransferase Containing 5-Azacytosine Residues at Specific Sites

Ramon Güimil García, Adam S. Brank, Judith K. Christman [...]

Nucleic Acid Therapeutics

Open access

Review article

First published 2022

Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria

Raymond S.M. Wong

Therapeutic Advances in Hematology

Open access

Research article

First published 2024

Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study

James F. Howard, Saskia Bresch, Constantine Farmakidis [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2020

One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study

Hubert Schrezenmeier, Austin Kulasekararaj, Lindsay Mitchell [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 1995-04

Protection of Retroviral Vector Particles in Human Blood Through Complement Inhibition

Russell P. Rother, Stephen P. Squinto, James M. Mason [...]

Human Gene Therapy

Search results